Vol. 9 (11) pp. 602-607 DOI: 10.21474/IJAR01/13781

GENETIC RESISTANCE TO VITAMIN K ANTAGONISTS: NO DELAY IN INTRODUCING DIRECT ORAL ANTICOAGULANTS! A CASE REPORT

, , and
  • Ph D at Faculty of Sciences, Ibn Zohr University, Agadir, Morocco.
  • Laboratory of Biotchnologies and Valorisation of Natural Resources (LBVRN), Ibn Zohr University, Agadir, Morocco.
26 Downloads 108 Views
Crossref

Download Full Paper (PDF)

Abstract

Because of their cost and the large amount of experience, vitamin k antagonists are widely prescribed in the world for the prevention and treatment of thrombosis. However, cases of resistance to VKA exist, although they are difficult to authenticate. Direct oral anticoagulants DOA represent a good alternative. We report a case of true hemodynamic and genetic resistance to VKA in which rivaroxaban was the solution.

Keywords

How to Cite This Article

Benyamna I., Bouzid F., El Mousadik A. and Alif N. (2021); GENETIC RESISTANCE TO VITAMIN K ANTAGONISTS: NO DELAY IN INTRODUCING DIRECT ORAL ANTICOAGULANTS! A CASE REPORT, International Journal of Advanced Research (IJAR), 9 (11), 602-607, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/13781

Corresponding Author

Benyamna I
Cardiologist and Ph D at Ibn Zohr University, Faculty of sciences

Article Analytics

Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.